tadalafil has been researched along with Substance-Related Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffiths, A; Hadley, L | 1 |
| Costabile, R; Lowe, G | 1 |
1 review(s) available for tadalafil and Substance-Related Disorders
| Article | Year |
|---|---|
Phosphodiesterase type 5 inhibitor abuse: a critical review.
Topics: Carbolines; Drug Contamination; Humans; Imidazoles; Internet; Marketing; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Substance-Related Disorders; Sulfones; Tadalafil; Triazines; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride | 2011 |
1 other study(ies) available for tadalafil and Substance-Related Disorders
| Article | Year |
|---|---|
The prevalence of gamma-hydroxybutyrate (GHB) in motor vehicle drivers and its co-administration with amphetamine type substances (ATS) in Queensland, Australia (2011-2018).
Topics: Adult; Amphetamines; Australia; Benzodiazepines; Driving Under the Influence; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Narcotics; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Sodium Oxybate; Substance Abuse Detection; Substance-Related Disorders; Tadalafil | 2019 |